Profile data is unavailable for this security.
About the company
Teleflex Incorporated is a global provider of medical technologies. The Company offers a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. It primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates in three segments: the Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Its vascular access product portfolio includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous (bone access) systems. Its interventional product offerings consist of a portfolio of Arrow branded intra-aortic balloon pumps and catheters, GuideLiner, Turnpike and TrapLiner catheters, Pulsar-18 T3 Self-Expanding 4F Stent and Orsiro Mission Drug Eluting Stent.
- Revenue in USD (TTM)2.39bn
- Net income in USD58.53m
- Incorporated1943
- Employees15.50k
- LocationTeleflex Inc550 E Swedesford Rd, Suite 400WAYNE 19087United StatesUSA
- Phone+1 (610) 225-6800
- Fax+1 (610) 948-5101
- Websitehttps://www.teleflex.com/usa/en/#
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICU Medical Inc | 2.23bn | 732.00k | 3.52bn | 13.00k | 5,780.39 | 1.66 | 17.22 | 1.58 | 0.0247 | 0.0247 | 90.50 | 86.03 | 0.5406 | 2.35 | 12.28 | 171,635.50 | 0.0465 | -0.6518 | 0.0534 | -0.7376 | 36.84 | 34.16 | 0.0861 | -1.11 | 1.15 | 1.70 | 0.378 | -- | -6.33 | 11.91 | 100.62 | -61.53 | -0.6816 | -- |
| LivaNova PLC | 1.39bn | -242.47m | 3.74bn | 3.30k | -- | 3.12 | -- | 2.70 | -4.47 | -4.47 | 25.37 | 21.96 | 0.543 | 2.84 | 6.79 | 420,622.10 | -9.48 | -3.21 | -12.39 | -3.97 | 68.04 | 68.27 | -17.46 | -6.55 | 1.16 | 3.67 | 0.2389 | -- | 10.74 | 8.24 | -483.45 | -- | 18.27 | -- |
| iRhythm Holdings, Inc | 747.14m | -44.55m | 4.07bn | 2.40k | -- | 26.61 | -- | 5.44 | -1.41 | -1.41 | 23.35 | 4.73 | 0.7657 | 12.33 | 9.60 | 311,307.50 | -4.57 | -16.40 | -5.28 | -19.65 | 70.57 | 68.67 | -5.96 | -19.44 | 4.48 | -- | 0.8096 | -- | 26.24 | 23.02 | 60.67 | -- | 27.88 | -- |
| Merit Medical Systems Inc | 1.52bn | 128.49m | 4.45bn | 7.50k | 35.21 | 2.81 | 17.46 | 2.93 | 2.13 | 2.13 | 25.07 | 26.66 | 0.594 | 2.43 | 7.70 | 202,120.80 | 5.03 | 4.56 | 5.53 | 5.10 | 48.70 | 46.73 | 8.48 | 7.34 | 2.95 | 16.77 | 0.3166 | 0.00 | 11.75 | 9.48 | 6.76 | -- | 11.48 | -- |
| Stevanato Group SpA | 1.36bn | 163.27m | 4.46bn | 5.52k | 24.62 | 2.41 | 17.13 | 3.28 | 0.5982 | 0.5982 | 4.98 | 6.12 | 0.5058 | 2.95 | 2.65 | 246,184.70 | 6.08 | 8.02 | 7.63 | 10.94 | 29.27 | 31.01 | 12.01 | 13.24 | 1.30 | 30.00 | 0.2386 | 6.82 | 1.72 | 15.53 | -19.13 | 24.61 | 33.52 | -- |
| Envista Holdings Corp | 2.72bn | 47.00m | 4.70bn | 12.00k | 104.27 | 1.51 | 28.82 | 1.73 | 0.275 | 0.275 | 16.10 | 18.96 | 0.4931 | 4.62 | 6.86 | 226,625.00 | 0.8523 | -2.14 | 1.01 | -2.58 | 55.02 | 56.70 | 1.73 | -5.21 | 2.04 | 6.70 | 0.318 | -- | 8.32 | 7.11 | 104.20 | 2.03 | -1.03 | -- |
| TransMedics Group Inc | 605.49m | 188.99m | 5.08bn | 898.00 | 31.09 | 10.72 | 23.46 | 8.38 | 4.76 | 4.79 | 14.94 | 13.81 | 0.6467 | 5.09 | 6.65 | 674,269.50 | 20.19 | 4.75 | 21.93 | 5.18 | 59.92 | 61.27 | 31.21 | 8.52 | 6.59 | 84.70 | 0.5199 | 0.00 | 37.13 | 88.21 | 436.58 | -- | 164.81 | -- |
| Lantheus Holdings Inc | 1.54bn | 233.56m | 5.09bn | 1.19k | 23.45 | 4.67 | 16.77 | 3.30 | 3.36 | 3.36 | 22.33 | 16.87 | 0.7328 | 9.04 | 4.53 | 1,292,212.00 | 11.10 | 11.26 | 12.85 | 12.98 | 61.10 | 61.61 | 15.15 | 14.47 | 2.51 | -- | 0.3432 | 0.00 | 0.5019 | 35.35 | -25.25 | -- | 23.67 | -- |
| Teleflex Inc | 2.39bn | 58.53m | 5.40bn | 15.50k | 98.55 | 1.73 | 22.86 | 2.26 | 1.24 | -20.56 | 53.59 | 70.70 | 0.341 | 2.23 | 5.95 | 154,489.00 | 0.8335 | 3.12 | 0.9266 | 3.43 | 53.13 | 57.05 | 2.44 | 10.06 | 2.01 | 2.73 | 0.4581 | 28.48 | 17.25 | -4.72 | 2.34 | -29.49 | 0.9821 | 0.00 |
| Caris Life Sciences Inc | -100.00bn | -100.00bn | 5.47bn | -- | -- | 11.43 | -- | -- | -- | -- | -- | 1.70 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 9.36 | -- | 0.4404 | -- | 34.67 | -- | 18.22 | -- | -- | -- |
| Bruker Corp | 3.44bn | -22.50m | 5.98bn | 11.09k | -- | 2.43 | 30.02 | 1.74 | -0.1485 | -0.1485 | 22.63 | 16.15 | 0.5705 | 1.64 | 5.22 | 310,013.50 | -0.1212 | 5.07 | -0.1553 | 6.76 | 47.13 | 49.70 | -0.2124 | 7.56 | 0.8553 | 9.30 | 0.4268 | 13.19 | 2.08 | 11.57 | -119.89 | -- | 4.34 | 4.56 |
| Avantor Inc | 6.55bn | -530.20m | 5.99bn | 13.50k | -- | 1.08 | -- | 0.914 | -0.7775 | -0.7775 | 9.62 | 8.16 | 0.5481 | 5.70 | 6.21 | 485,348.20 | -4.44 | 2.78 | -5.17 | 3.18 | 32.65 | 33.77 | -8.09 | 5.00 | 1.18 | 3.62 | 0.4149 | 0.00 | -3.41 | 0.4913 | -174.52 | -- | 15.90 | -- |
| Glaukos Corp | 507.44m | -187.69m | 6.84bn | 1.09k | -- | 10.32 | -- | 13.48 | -3.27 | -3.27 | 8.87 | 11.41 | 0.5432 | 1.84 | 5.99 | 463,840.90 | -20.09 | -12.56 | -22.19 | -13.55 | 77.97 | 76.60 | -36.99 | -34.64 | 4.06 | -- | 0.094 | -- | 32.33 | 17.67 | -28.23 | -- | 28.47 | -- |
| Repligen Corp | 738.26m | 48.89m | 6.93bn | 2.00k | 142.38 | 3.29 | 54.31 | 9.39 | 0.8643 | 0.8643 | 13.05 | 37.39 | 0.2555 | 2.23 | 5.04 | 369,128.00 | 1.69 | 2.88 | 1.77 | 3.20 | 52.65 | 53.58 | 6.62 | 10.73 | 7.12 | -- | 0.2047 | 0.00 | 16.36 | 15.05 | 291.64 | -3.99 | -0.4706 | -- |
| Bio Rad Laboratories Inc | 2.58bn | 759.90m | 7.51bn | 7.45k | 10.04 | 1.01 | 8.11 | 2.91 | 27.91 | 27.91 | 94.69 | 276.16 | 0.2591 | 1.65 | 5.66 | 346,738.30 | 7.62 | -1.69 | 8.02 | -1.77 | 52.01 | 54.52 | 29.42 | -8.08 | 4.19 | -- | 0.139 | -- | 0.6507 | 0.2935 | 141.20 | -27.58 | 7.74 | -- |
Data as of Mar 03 2026. Currency figures normalised to Teleflex Inc's reporting currency: US Dollar USD
60.00%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 31 Dec 2025 | 4.97m | 11.25% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 4.41m | 9.97% |
| T. Rowe Price Investment Management, Inc.as of 31 Dec 2025 | 4.36m | 9.86% |
| Janus Henderson Investors US LLCas of 31 Dec 2025 | 4.22m | 9.56% |
| AQR Capital Management LLCas of 31 Dec 2025 | 1.92m | 4.35% |
| Atlanta Capital Management Co. LLCas of 31 Dec 2025 | 1.82m | 4.12% |
| SSgA Funds Management, Inc.as of 31 Dec 2025 | 1.48m | 3.35% |
| Cooke & Bieler LPas of 31 Dec 2025 | 1.18m | 2.68% |
| Dimensional Fund Advisors LPas of 31 Dec 2025 | 1.17m | 2.65% |
| Geode Capital Management LLCas of 31 Dec 2025 | 985.68k | 2.23% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
